logo

For the Inventor, By the Inventor

Hayes, United Kingdom

Liqmeds Worldwide Limited


USPTO Granted Patents = 40

Forward Citations = 23

Loading Chart...
Loading Chart...

13 inventors (with patents filed for the assignee):

goldMedal Jayanta Kumar Mandal (35 out of 51 patents)

silverMedal Sandip Pareshbhai Mehta (29 out of 44 patents)

bronzeMedal Manish Kumar Umrethia (26 out of 41 patents)

4.  Jinal Pandya (13 out of 14 patents)

5.  Hiren Pansuriya (13 out of 14 patents)

6.  Henil Alpeshbhai Patel (8 out of 9 patents)

7.  Michael Paul DeHart (6 out of 16 patents)

8.  Swati Nagar (6 out of 10 patents)

9.  Malay Patel (6 out of 6 patents)

10.  Chintan Pansara (3 out of 3 patents)

11.  Ronak Patel (1 out of 2 patents)

12.  Vijay Patel (1 out of 4 patents)

13.  Mahesh Bhadgale (1 out of 1 patent)


Core Competencies:
Liquid Formulation
PDE V Inhibitors
Oral Dosage
Rivaroxaban
Aqueous Suspension
Clonidine
Vigabatrin
Losartan
Amlodipine
Mycophenolate
Sildenafil
Tadalafil

40 patents:

1. 12758492 - Aqueous suspension suitable for oral administration (2026-10-13),
2. 12751947 - Oral liquid formulation of apixaban (2026-10-06),
3. 12734175 - Liquid oral formulations for PDE V inhibitors (2026-09-15),
4. 12721849 - Liquid oral formulations for PDE V inhibitors (2026-09-01),
5. 12697338 - Liquid oral formulations for PDE V inhibitors (2026-08-04),
6. 12691120 - Liquid oral formulations for PDE V inhibitors (2026-07-28),
7. 12648950 - Oral liquid formulation of rivaroxaban (2026-06-09),
8. 12599553 - Aqueous suspension suitable for oral administration (2026-04-14),
9. 12551466 - Ready-to-use oral liquid formulation of clonidine (2026-02-17),
10. 12539300 - Method of treating seizures and epilepsy using liquid pharmaceutical composition for oral dosage of vigabatrin (2026-02-03),
11. 12496291 - Ready-to-use non-aqueous oral solution of losartan (2025-12-16),
12. 12440441 - Pharmaceutical solution of amlodipine (2025-10-14),
13. 12390439 - Oral liquid formulation of methocarbamol (2025-08-19),
14. 12370136 - Aqueous suspension suitable for oral administration (2025-07-29),
15. 12343338 - Ramipril solution for oral dosage (2025-07-01),
Company Overview
Liqmeds Worldwide Limited is a UK-based company specializing in the development and manufacturing of innovative liquid medication delivery systems. The organization focuses on enhancing patient compliance and safety through advanced technology solutions in the pharmaceutical sector. With a commitment to improving healthcare outcomes, Liqmeds leverages its expertise in drug formulation and delivery mechanisms to address the evolving needs of patients and healthcare providers globally.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

40 Patents

#2 in Hayes

#443 in United Kingdom

#17,087 in the World

Hayes, GB
Hayes, United Kingdom

Liqmeds Worldwide Limited

Forward Citations = 23

13 inventors:

goldMedal Jayanta Kumar Mandal (35 out of 51 patents)

silverMedal Sandip Pareshbhai Mehta (29 out of 44 patents)

bronzeMedal Manish Kumar Umrethia (26 out of 41 patents)

4.  Jinal Pandya (13 out of 14 patents)

5.  Hiren Pansuriya (13 out of 14 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Liqmeds Worldwide Limited. Retrieved from https://idiyas.com/company/liqmeds-worldwide

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…